Late and chronic antibody-mediated rejection: main barrier to long term graft survival

Area of Science:

• Transplantation immunology
• Organ transplant rejection
• Immunopathology

Background:

• Antibody-mediated rejection (AMR) is a significant factor in organ transplant failure.
• Anti-donor-specific antibodies, particularly anti-HLA antibodies, drive AMR.
• C4d was a diagnostic marker, but late/chronic AMR poses a persistent challenge.

Purpose of the Study:

• To review evidence on late/chronic AMR as a cause of graft loss.
• To describe the characteristics of late AMR.
• To discuss current management strategies for late/chronic AMR.

Main Methods:

• Literature review of studies on antibody-mediated rejection.
• Analysis of evidence linking late AMR to graft loss.
• Synthesis of data on AMR characteristics and treatment outcomes.

Main Results:

• Late and chronic AMR are primary causes of late graft loss.
• Early AMR treatments show limited efficacy in late/chronic stages.
• Effective long-term management strategies for late AMR are lacking.

Conclusions:

• Late/chronic AMR significantly impacts long-term organ transplant survival.
• There is a critical need for improved management strategies for late AMR.
• Further research and clinical efforts are required to enhance long-term graft survival in AMR cases.